NCT00773123

Brief Summary

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion cell layer thickness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2008

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 16, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

October 16, 2008

Status Verified

October 1, 2008

Enrollment Period

2 months

First QC Date

October 15, 2008

Last Update Submit

October 15, 2008

Conditions

Primary Open Angle Glaucoma

Keywords

RT-ViewSpectral domain OCTGanglion cell layerRNFLVisual field defect

Outcome Measures

Primary Outcomes (1)

  • Ganglion cell layer thickness

    1 month

Secondary Outcomes (1)

  • Visual field defect

    1 month

Study Arms (2)

1

Primary open angle glaucoma

2

Normal controls

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

primary open angle glaucoma

You may not qualify if:

  • Evidence of retinal disease
  • Neovascular glaucoma
  • Secondary glaucoma due to intraocular inflammation
  • Lens induced glaucoma
  • Tumor induced glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine

Seoul, 120-752, South Korea

RECRUITING

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Central Study Contacts

Chan Yun Kim, MD,PhD

CONTACT

82-2-2228-3570kangeye@hotmail.com

Sung Yong Kang, MD

CONTACT

82-2-2228-3570kangeye@yuhs.ac

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 15, 2008

First Posted

October 16, 2008

Study Start

October 1, 2008

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

October 16, 2008

Record last verified: 2008-10

Locations

KR(1)